The diagnosis of DCM was established according to the Chinese Guidelines for the Diagnosis and Treatment of Dilated Cardiomyopathy (2018), based on echocardiographic evidence of significant ventricular dilation and systolic dysfunction, along with markedly elevated pro-BNP levels. The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.